Hiv Drug
- All
- News
- Videos
-
Why 'Bluetoothing', A Shocking Blood-Sharing Trend To Get High, Has Health Experts Worried
Bluetoothing is a practice where one person injects themselves with a drug, then another person injects that first users blood into their own body
-
HIV-Prevention Drug To Be Available For Rs 3,500 A Year From 2027
Generic versions of a groundbreaking injectable HIV-prevention drug should be available for $40 or Rs 3,548 a year in more than 100 countries from 2027, Unitaid and the Gates Foundation said Wednesday.
-
EU Regulator Approves Twice-Yearly Injectable Drug For HIV Prevention
The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV, which scientists say could help end the virus' transmission.
-
Why We Still Need A Cure For HIV Despite Powerful Treatments
Over the past three decades there have been amazing advances in treating and preventing HIV.
-
Revolutionary New Drug Offers 99.9% Protection Against HIV
The US FDA has approved lenacapavir, a groundbreaking long-acting HIV prevention drug that offers near-complete protection with just two injections per year. Despite its potential, concerns about high costs may limit its global impact.
-
Sex Workers, Drug Addicts, HIV Patients: An Outcast Haven On Ukraine Front
Whenever warm days come to Kramatorsk, near the eastern Ukrainian front, the Svitanok organisation leaves its door wide open, offering advice or a cup of tea to the city's social outcasts.
-
Lenacapavir: The 'Breakthrough Of The Year' Drug For HIV Care
A significant breakthrough in treating the Human Immunodeficiency Virus (HIV) came recently with the US Federal Drug Administration (FDA) approving lenacapavir, a new prototype medication.
-
New "Vaccine-Like" HIV Drug Could Cost 1,000 Times Less Than Current Price
A new "vaccine-like" HIV drug that currently costs over $40,000 per person a year could be made for as little as $40, researchers estimated on Tuesday.
-
Injection Twice A Year 100% Effective In HIV Treatment: Study
A large clinical trial in South Africa and Uganda has shown that a twice-yearly injection of a new pre-exposure prophylaxis drug gives young women total protection from HIV infection.
-
4 Children Become HIV Positive After Blood Transfusion In Nagpur, 1 Dies
The Food and Drugs Department (FDA) has also started a preliminary investigation into the case.
-
Omicron-Like Variants Could Be Stifled By AIDS Treatment Programs: Report
South Africa should boost the provision of antiretroviral drugs for millions of people infected with HIV to potentially reduce the chance of new Covid-19 variants to emerge, scientists said.
-
2nd HIV Patient Whose Body Rid Itself Of Virus Identified By Scientists
The world's second HIV patient whose body appears to have rid itself off the virus without the use of antiretroviral drugs has been identified, scientists said on Tuesday.
-
IIT Madras Researchers Working On New Way To Develop More Effective Drugs Against HIV-AIDS
The research team has found that introducing electrostatic interaction sites on potential drug molecules can enhance the efficacy of antiviral drugs against the HIV virus.
-
IIT Madras Researchers Working On Effective Drugs Against HIV/AIDS
Researchers at the Indian Institute of Technology, Madras, are engaged in developing a new idea that can pave the way for effective treatment of HIV/AIDS, a senior professor said on Thursday.
-
HIV Treatment Has No Benefit For Hospitalised COVID-19 Patients: Study
A combination of antiviral drugs usually used to treat HIV has no beneficial effect in patients hospitalised with COVID-19, a peer-reviewed study said on Monday, confirming the initial results of a large-scale randomised trial of the drug.
-
Why 'Bluetoothing', A Shocking Blood-Sharing Trend To Get High, Has Health Experts Worried
Bluetoothing is a practice where one person injects themselves with a drug, then another person injects that first users blood into their own body
-
HIV-Prevention Drug To Be Available For Rs 3,500 A Year From 2027
Generic versions of a groundbreaking injectable HIV-prevention drug should be available for $40 or Rs 3,548 a year in more than 100 countries from 2027, Unitaid and the Gates Foundation said Wednesday.
-
EU Regulator Approves Twice-Yearly Injectable Drug For HIV Prevention
The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV, which scientists say could help end the virus' transmission.
-
Why We Still Need A Cure For HIV Despite Powerful Treatments
Over the past three decades there have been amazing advances in treating and preventing HIV.
-
Revolutionary New Drug Offers 99.9% Protection Against HIV
The US FDA has approved lenacapavir, a groundbreaking long-acting HIV prevention drug that offers near-complete protection with just two injections per year. Despite its potential, concerns about high costs may limit its global impact.
-
Sex Workers, Drug Addicts, HIV Patients: An Outcast Haven On Ukraine Front
Whenever warm days come to Kramatorsk, near the eastern Ukrainian front, the Svitanok organisation leaves its door wide open, offering advice or a cup of tea to the city's social outcasts.
-
Lenacapavir: The 'Breakthrough Of The Year' Drug For HIV Care
A significant breakthrough in treating the Human Immunodeficiency Virus (HIV) came recently with the US Federal Drug Administration (FDA) approving lenacapavir, a new prototype medication.
-
New "Vaccine-Like" HIV Drug Could Cost 1,000 Times Less Than Current Price
A new "vaccine-like" HIV drug that currently costs over $40,000 per person a year could be made for as little as $40, researchers estimated on Tuesday.
-
Injection Twice A Year 100% Effective In HIV Treatment: Study
A large clinical trial in South Africa and Uganda has shown that a twice-yearly injection of a new pre-exposure prophylaxis drug gives young women total protection from HIV infection.
-
4 Children Become HIV Positive After Blood Transfusion In Nagpur, 1 Dies
The Food and Drugs Department (FDA) has also started a preliminary investigation into the case.
-
Omicron-Like Variants Could Be Stifled By AIDS Treatment Programs: Report
South Africa should boost the provision of antiretroviral drugs for millions of people infected with HIV to potentially reduce the chance of new Covid-19 variants to emerge, scientists said.
-
2nd HIV Patient Whose Body Rid Itself Of Virus Identified By Scientists
The world's second HIV patient whose body appears to have rid itself off the virus without the use of antiretroviral drugs has been identified, scientists said on Tuesday.
-
IIT Madras Researchers Working On New Way To Develop More Effective Drugs Against HIV-AIDS
The research team has found that introducing electrostatic interaction sites on potential drug molecules can enhance the efficacy of antiviral drugs against the HIV virus.
-
IIT Madras Researchers Working On Effective Drugs Against HIV/AIDS
Researchers at the Indian Institute of Technology, Madras, are engaged in developing a new idea that can pave the way for effective treatment of HIV/AIDS, a senior professor said on Thursday.
-
HIV Treatment Has No Benefit For Hospitalised COVID-19 Patients: Study
A combination of antiviral drugs usually used to treat HIV has no beneficial effect in patients hospitalised with COVID-19, a peer-reviewed study said on Monday, confirming the initial results of a large-scale randomised trial of the drug.
